HEMATOPOIETIC CELL TRANSPLANTATION RECIPIENT
Clinical trials for HEMATOPOIETIC CELL TRANSPLANTATION RECIPIENT explained in plain language.
Never miss a new study
Get alerted when new HEMATOPOIETIC CELL TRANSPLANTATION RECIPIENT trials appear
Sign up with your email to follow new studies for HEMATOPOIETIC CELL TRANSPLANTATION RECIPIENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New Radiation-Chemo cocktail aims to boost stem cell transplant success in tough leukemias
Disease control TerminatedThis phase 1 trial is testing a combination of total marrow and lymphoid irradiation (TMLI) plus two chemotherapy drugs, fludarabine and melphalan, given before a donor stem cell transplant. The goal is to find the safest dose of radiation that can kill cancer cells while prepari…
Matched conditions: HEMATOPOIETIC CELL TRANSPLANTATION RECIPIENT
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jul 02, 2026 02:00 UTC
-
New drug combo aims to keep myeloma in check after transplant
Disease control OngoingThis phase II trial tests whether adding elotuzumab to standard lenalidomide maintenance therapy can prevent multiple myeloma from returning after an autologous stem cell transplant. About 113 newly diagnosed patients who had a transplant will receive the combination. The goal is…
Matched conditions: HEMATOPOIETIC CELL TRANSPLANTATION RECIPIENT
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Tracking childhood cancer survivors for decades to improve their future health
Knowledge-focused OngoingThis long-term study follows 5,000 childhood cancer survivors who had a stem cell transplant or treatment for leukemia or solid tumors. Researchers collect health updates and quality-of-life questionnaires over 20+ years to understand late effects of therapy. The goal is to reduc…
Matched conditions: HEMATOPOIETIC CELL TRANSPLANTATION RECIPIENT
Sponsor: Children's Oncology Group • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:04 UTC